Clarivate is betting that a narrower company is a stronger one. The July 2026 agreement to sell Life Sciences and Healthcare to Altaris for $600 million would leave Clarivate concentrated on Academia and Government plus Intellectual Property, funding debt reduction from the proceeds. The same quarter, Q2 2026 revenue fell 5.5%, organic revenue fell 1.5%, and the company took a $221.7 million goodwill impairment charge.
One thing worth flagging: management has tied the plan to specific, falsifiable outcomes, including higher recurring revenue mix, positive organic ACV growth, and margin expansion to 42% or higher by year end. With transactional revenue down 30.1% in the same quarter the divestiture was announced, the plan's credibility depends on the core business turning a corner that has not yet shown up in the numbers. This Dossier lays out what would resolve each question, and why neither is settled by the public record alone.
Sources and Methods
Dossiers are built from primary documents: SEC filings, earnings call and investor day transcripts, management presentations, press releases, and trade press. We also work the channels where product and operating problems surface before they reach an earnings call, including App Store, Google Play, and Trustpilot reviews, and structured sentiment research on Reddit Answers. Equity analyst commentary is used to map where the sell side disagrees and is treated as opinion, not evidence.
The Intelligence Council is editorially independent. No company reviews a Dossier before publication.
This is our initiating coverage, including Q2 2026 results. Updates to post quarterly.
Access the Dossier here: Clarivate (NYSE: CLVT)
What’s Inside This Dossier
The Central Question. The single unresolved strategic question on which the company is being judged, along with a dated scorecard of where each proof point currently stands.
Vital Signs. Revenue, enrollment or user metrics, retention, margin, and the other numbers that separate the bull and bear case, pulled directly from filings and earnings calls.
What This Means For You. Distinct, action-oriented implications for competitors and vendors, buyers, and partners and investors.
Signals Dashboard. Six categories of forward-looking indicators, from customer momentum to governance risk, each with a status and the evidence behind it.
Market Reality Check. Where the analyst community actually splits, what management won't answer directly on earnings calls, and whether discovery and engagement are growing or shrinking.
Commercial Momentum. What the company signed, launched, retreated from, and let go, across product, distribution, and partnerships, in one view.
Competitive Position. The specific mechanism by which each real competitor is gaining or losing ground, not a list of names.
Business Model Anatomy. How the company's revenue mix actually breaks down, and what has structurally changed in pricing, distribution, or the underlying model in the last 24 months.
View All Companies Covered here: Education Dossiers
Disclaimer
A Dossier is not a stock recommendation and not an equity research product. It is independent competitive intelligence prepared for operating executives, and nothing in it constitutes investment advice or an offer to buy or sell any security. The Intelligence Council is not affiliated with, endorsed by, or compensated by any company for being covered in a Dossier. Analysis is built from sources believed to be reliable, though we make no warranty as to completeness or accuracy. Judgments and forward-looking assessments reflect our view as of the publication date and are subject to change without notice. Company names and marks are the property of their respective owners.
License
Dossiers are licensed to the named subscriber and may not be redistributed, resold, or republished outside the subscribing individual or organization, depending on the subscriber's license, without written permission. Excerpting for internal use is permitted with attribution to The Intelligence Council.
The Dossier is for the people who run the education ecosystem: institutional leaders, workforce and L&D buyers, and the founders, investors, and GTM executives who sell to them.
Ping us at [email protected] if you’d like to learn more, explore Enterprise Access, or would like to partner in other ways.
The Intelligence Council is a next-gen B2B media and business intelligence platform built for people who make strategy, allocate capital, and carry operating risk.